Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  midazolam hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-19 of 19 for your search:
Start Over
Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 21
Sponsor: Other
Protocol IDs: PK01/16/08, NCT00808184
Quality Study of Anesthetic Technique on Breast Cancer Surgery
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 20110920A, NCT01499836
Phase II Study of Antiemesis with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving High-Dose Cisplatin (Summary Last Modified 07/90)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-88143, NCI-V89-0039
Phase I Study of Nelfinavir Mesylate in Patients With Metastatic, Refractory, or Recurrent Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-07-C-0047, NCI-P6880, NCT00436735
A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: NP22676, NCT01001299
Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-044, 2010_511, NCT01071304
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02916, CDR0000685426, CO09908, 8516, P30CA014520, U01CA062491, WCCC-CO-09908, NCT01218620
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107A2128, 2009-009425-28, NCT01223898
BAY73-4506 Probe Substrate Study
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12434, NCT01287598
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U158, NCT01517399
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INT12497, U1111-1125-8930, NCT01585623
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTKI258A2119, 2011-001489-16, NCT01596647
A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OPZ009, NCT02244112
Trial of Antiemetic Therapy with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving Cisplatin for Malignancies (Summary Last Modified 08/90)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-89098, NCI-V89-0193
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-000848, NCT00578214
Compare Propofol to Fentanyl and Midazolam for Colonoscopy
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RCCS 262, NCT01488045
Performance of Endoscopic Submucosal Dissection According to the Sedation Method
Phase: No phase specified
Type: Health services research, Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Other
Protocol IDs: 4-2012-0661, NCT01806753
Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 20 to 65
Sponsor: Other
Protocol IDs: 4-2013-0444, NCT01945476
Prothrombotic Factors and Anaesthesia in Prostate Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 40 to 80
Sponsor: Other
Protocol IDs: 550, NCT01998685
Start Over